117 related articles for article (PubMed ID: 26587865)
21. Thermal behavior and molecular mobility studies in the supercooled liquid and glassy states of carvedilol and loratadine.
Viciosa MT; Moura Ramos JJ; Diogo HP
Int J Pharm; 2020 Jun; 584():119410. PubMed ID: 32445909
[TBL] [Abstract][Full Text] [Related]
22. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
Meng F; Gala U; Chauhan H
Drug Dev Ind Pharm; 2015; 41(9):1401-15. PubMed ID: 25853292
[TBL] [Abstract][Full Text] [Related]
23. Freezing-in and production of entropy in vitrification.
Möller J; Gutzow I; Schmelzer JW
J Chem Phys; 2006 Sep; 125(9):094505. PubMed ID: 16965095
[TBL] [Abstract][Full Text] [Related]
24. Is there a correlation between the glass forming ability of a drug and its supersaturation propensity?
Blaabjerg LI; Lindenberg E; Löbmann K; Grohganz H; Rades T
Int J Pharm; 2018 Mar; 538(1-2):243-249. PubMed ID: 29341914
[TBL] [Abstract][Full Text] [Related]
25. Role of viscosity in influencing the glass-forming ability of organic molecules from the undercooled melt state.
Baird JA; Santiago-Quinonez D; Rinaldi C; Taylor LS
Pharm Res; 2012 Jan; 29(1):271-84. PubMed ID: 21786040
[TBL] [Abstract][Full Text] [Related]
26. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques.
van Drooge DJ; Hinrichs WL; Visser MR; Frijlink HW
Int J Pharm; 2006 Mar; 310(1-2):220-9. PubMed ID: 16427226
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of amorphous solid dispersion properties using thermal analysis techniques.
Baird JA; Taylor LS
Adv Drug Deliv Rev; 2012 Apr; 64(5):396-421. PubMed ID: 21843564
[TBL] [Abstract][Full Text] [Related]
29. Influence of copolymer composition on the phase behavior of solid dispersions.
Prudic A; Kleetz T; Korf M; Ji Y; Sadowski G
Mol Pharm; 2014 Nov; 11(11):4189-98. PubMed ID: 25295846
[TBL] [Abstract][Full Text] [Related]
30. Impact of Intermolecular Interactions, Dimeric Structures on the Glass Forming Ability of Naproxen, and a Series of Its Derivatives.
Minecka A; Kaminska E; Tarnacka M; Grudzka-Flak I; Bartoszek M; Wolnica K; Dulski M; Kaminski K; Paluch M
Mol Pharm; 2018 Oct; 15(10):4764-4776. PubMed ID: 30156420
[TBL] [Abstract][Full Text] [Related]
31. Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir.
Mosquera-Giraldo LI; Taylor LS
Mol Pharm; 2015 Feb; 12(2):496-503. PubMed ID: 25541813
[TBL] [Abstract][Full Text] [Related]
32. Structural signature of slow dynamics and dynamic heterogeneity in two-dimensional colloidal liquids: glassy structural order.
Kawasaki T; Tanaka H
J Phys Condens Matter; 2011 May; 23(19):194121. PubMed ID: 21525551
[TBL] [Abstract][Full Text] [Related]
33. Effect of counterions on the properties of amorphous atorvastatin salts.
Sonje VM; Kumar L; Puri V; Kohli G; Kaushal AM; Bansal AK
Eur J Pharm Sci; 2011 Nov; 44(4):462-70. PubMed ID: 21907794
[TBL] [Abstract][Full Text] [Related]
34. Stabilization of low glass transition temperature indomethacin formulations: impact of polymer-type and its concentration.
Chokshi RJ; Shah NH; Sandhu HK; Malick AW; Zia H
J Pharm Sci; 2008 Jun; 97(6):2286-98. PubMed ID: 17879977
[TBL] [Abstract][Full Text] [Related]
35. Applications of KinetiSol dispersing for the production of plasticizer free amorphous solid dispersions.
DiNunzio JC; Brough C; Miller DA; Williams RO; McGinity JW
Eur J Pharm Sci; 2010 Jun; 40(3):179-87. PubMed ID: 20230894
[TBL] [Abstract][Full Text] [Related]
36. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
[TBL] [Abstract][Full Text] [Related]
37. Physical stability of the amorphous state of loperamide and two fragment molecules in solid dispersions with the polymers PVP-K30 and PVP-VA64.
Weuts I; Kempen D; Decorte A; Verreck G; Peeters J; Brewster M; Van den Mooter G
Eur J Pharm Sci; 2005 Jun; 25(2-3):313-20. PubMed ID: 15911228
[TBL] [Abstract][Full Text] [Related]
38. Isothermal microcalorimetry to investigate the phase separation for amorphous solid dispersions of AMG 517 with HPMC-AS.
Calahan JL; Zanon RL; Alvarez-Nunez F; Munson EJ
Mol Pharm; 2013 May; 10(5):1949-57. PubMed ID: 23574401
[TBL] [Abstract][Full Text] [Related]
39. Correlation between glass-forming ability and fragility of pharmaceutical compounds.
Kawakami K; Harada T; Yoshihashi Y; Yonemochi E; Terada K; Moriyama H
J Phys Chem B; 2015 Apr; 119(14):4873-80. PubMed ID: 25781503
[TBL] [Abstract][Full Text] [Related]
40. Anomalous role change of tertiary amino and ester groups as hydrogen acceptors in eudragit E based solid dispersion depending on the concentration of naproxen.
Ueda H; Wakabayashi S; Kikuchi J; Ida Y; Kadota K; Tozuka Y
Mol Pharm; 2015 Apr; 12(4):1050-61. PubMed ID: 25654583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
